Synergistic inhibition of Notch signaling and forced cell cycle re-entry drive Müller glia reprogramming in uninjured mouse retina
eLife · 2026
DOI: 10.7554/elife.111251 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Baoshan Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Receptors, Notch, Signal Transduction, Ependymoglial Cells, Cell Cycle. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council, University Grants Committee, Health and Medical Research Fund.
Abstract (Originalsprache)
In regenerative species, such as teleost fish, Müller glia (MG) autonomously re-enter the cell cycle after injury and give rise to functional retinal neurons. In contrast, the loss of retinal neurons in mammals is irreversible due to the limited proliferative and regenerative ability of MG. Various strategies have been developed to induce proliferation of mature mouse MG with or without injury, yet most MG daughter cells retain glial cell fate. Here, we found that MG progenies maintain high Notch signaling, which may constrain their neurogenic potential. Conditional deletion of Rbpj , the central transcriptional effector of Notch, induced limited MG-to-neuron conversion in mature MG without proliferation. However, Rbpj deletion, combined with forced MG proliferation by overexpressing Ccnd1 and suppressing Cdkn1b , significantly promoted MG dedifferentiation and ectopic expression of the neuronal marker Otx2 in MG daughter cells in uninjured mouse retina. Combining Notch inhibition with MG cell cycle re-activation not only increased the numbers of bipolar- and amacrine-like cells generated from MG but also promoted the further differentiation toward ON-cone, OFF-cone, and rod-bipolar subtypes. Single-nucleus RNA and ATAC sequencing data revealed that Notch inhibition facilitated the formation of MG-derived progenitor-like cells while MG proliferation increased chromatin accessibility of neurogenic genes. Notably, most MG-derived cells survived long term despite incomplete maturation. Together, our findings delineate how Notch inhibition and MG proliferation, alone or in combination, influence the regenerative potential of MG in the mammalian retina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong, China.
- Department of Biomedical Engineering, College of Biomedicine, City University of Hong Kong, Hong Kong, China.
- Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE), Tai Po, China.
- Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
ORCID-Profile: Baoshan Liao, Chengshang Lyu, Qinrong Zhang, Wenjun Xiong
Förderung
- Research Grants Council, University Grants Committee
- Health and Medical Research Fund
Zitieren
APA
Liao, B., Lyu, C., Jiang, Y., Liu, S., Wong, W., Zhang, J., Tsang, H., Xie, J., Chen, L., Zhang, Q., & Xiong, W. (2026). Synergistic inhibition of Notch signaling and forced cell cycle re-entry drive Müller glia reprogramming in uninjured mouse retina. eLife. https://doi.org/10.7554/elife.111251
Vancouver
Liao B, Lyu C, Jiang Y, Liu S, Wong W, Zhang J, et al. Synergistic inhibition of Notch signaling and forced cell cycle re-entry drive Müller glia reprogramming in uninjured mouse retina. eLife. 2026. doi:10.7554/elife.111251
BibTeX
@article{Liao2026,
author = {Liao, Baoshan and Lyu, Chengshang and Jiang, Yuqing and Liu, Shanggong and Wong, Waiho and Zhang, Jiadong and Tsang, Hoyin and Xie, Junxi and Chen, Lingxi and Zhang, Qinrong and Xiong, Wenjun},
title = {Synergistic inhibition of Notch signaling and forced cell cycle re-entry drive Müller glia reprogramming in uninjured mouse retina},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.111251}
}
EUVIMED